Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Senestech, Inc. (SNES : NSDQ)

• Company Description    SenesTech, Inc. developed technology for managing animal pest populations through fertility control as opposed to a lethal approach. The Company's fertility control product candidate, ContraPest(R), will be marketed for use initially in controlling rat infestations. SenesTech, Inc. is based in Flagstaff, Arizona. Number of Employees: 23

• Price / Volume Information    Yesterday's Closing Price: $4.98 Daily Weekly Monthly 20 Day Moving Average: 88,162 shares Shares Outstanding: 4.94 (millions) Market Capitalization: $24.62 (millions) Beta: 0.27 52 Week High: $6.24 52 Week Low: $1.30 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 8.03% 6.08% 12 Week 17.18% 6.39% Year To Date 50.45% 34.33%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 13430 North Dysart Road Suite 105 - Surprise,AZ 85379 USA ph: 928-779-4143 fax: - senestech@lythampartners.com http://www.senseonics.com

• General Corporate Information    Officers Joel Fruendt - President and Chief Executive Officer Jamie Bechtel - Chair of the Board Thomas C. Chesterman - Executive Vice President; Chief Financial Officer; Phil Grandinetti - Director Jake Leach - Director Peer Information Senestech, Inc. (BJCT) Senestech, Inc. (CADMQ) Senestech, Inc. (APNO) Senestech, Inc. (UPDC) Senestech, Inc. (IMTIQ) Senestech, Inc. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 81720R604 SIC: 2870 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/11/25 Share - Related Items Shares Outstanding: 4.94 Most Recent Split Date: 7.00 (0.10:1) Beta: 0.27 Market Capitalization: $24.62 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.35 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-2.83 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/11/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 2.69 Price/Cash Flow: - Price / Sales: 11.76 EPS Growth vs. Year Ago Period: 71.75% vs. Previous Quarter: 32.03% Sales Growth vs. Year Ago Period: 36.17% vs. Previous Quarter: 28.87% ROE 06/30/25 - -150.93 03/31/25 - -197.80 12/31/24 - -178.14 ROA 06/30/25 - -111.41 03/31/25 - -156.39 12/31/24 - -143.51 Current Ratio 06/30/25 - 9.23 03/31/25 - 5.83 12/31/24 - 5.01 Quick Ratio 06/30/25 - 8.35 03/31/25 - 4.44 12/31/24 - 3.60 Operating Margin 06/30/25 - -289.01 03/31/25 - -312.25 12/31/24 - -333.01 Net Margin 06/30/25 - -289.01 03/31/25 - -312.25 12/31/24 - -333.01 Pre-Tax Margin 06/30/25 - -289.01 03/31/25 - -312.25 12/31/24 - -333.01 Book Value 06/30/25 - 1.85 03/31/25 - 1.63 12/31/24 - 2.42 Inventory Turnover 06/30/25 - 0.96 03/31/25 - 0.90 12/31/24 - 0.99 Debt-to-Equity 06/30/25 - 0.03 03/31/25 - 0.07 12/31/24 - 0.08 Debt-to-Capital 06/30/25 - 2.45 03/31/25 - 6.20 12/31/24 - 7.58

Powered by Zacks Investment Research ©